logo-loader

Faron Pharmaceuticals applies to list shares on Nasdaq First North Growth Market

Published: 08:07 21 Nov 2019 GMT

Faron Pharmaceuticals Ltd -

Faron Pharmaceuticals Oy (LON:FARN) has applied to have its shares listed on the Nasdaq First North Growth Market.

This provides investors in the company’s native Finland, many of whom backed the last fundraiser, to trade shares on a local exchange.

Pending the application approval, the stock will begin trading on December 1.

Faron Pharmaceuticals reports promising phase 1 results from BEXMAB study

Faron Pharmaceuticals Limited (AIM:FARN) chief executive Dr Markku Jalkanen joins Proactive's Stephen Gunnion with additional positive data from the Phase 1 study of the ongoing bexmarilimab (BEXMAB) trial that has moved into Phase 2 for higher-risk (HR) myelodysplastic syndrome (MDS) patients...

1 week, 3 days ago